Original Research

Gender and Patient Satisfaction in a Veterans Health Administration Outpatient Chemotherapy Unit

Author and Disclosure Information

 

References

Limitations

Limitations to our study include the overall small sample size. This is due to the combination of the low number of women treated at VAPHCS and many with advanced cancer who, unfortunately, have a limited overall survival and hinders accrual of a larger sample size. Other limitations included age as a possible confounder in our findings, with women representing a younger demographic compared with men. We did not collect responses on duration of infusion time, which also may impact overall satisfaction and patient experience. We also acknowledge that biologic male or female sex may not correspond to a specific individual’s gender. Use of CPRS to obtain a matched number of male and female patients through random selection relied on labeled data from the EHR. This potentially may have excluded male patients who identify as another gender that would have been captured on the anonymous survey.Last, we restricted survey responses to online only, which excluded a small percentage who declined this approach.

Conclusions

Our findings may have broad applications to other VHA facilities and other cancer-directed treatment centers where the patient demographic and open shared infusion unit design may be similar. The study also may serve as a model of survey design and implementation from which other centers may consider improving patient satisfaction. We hope these survey results and interventions can provide insight and be used to improve patient satisfaction among all cancer patients at infusion units serving veterans and nonveterans.

Acknowledgments

We are very thankful to our cancer patients who took the time to take the survey. We also are very grateful to the VHA infusion unit nurses, staff, nurse practitioners, and physicians who have embraced this project and welcomed any changes that may positively impact treatment of veterans. Also, thank you to Tia Kohs for statistical support and Sophie West for gender discussions. Last, we specifically thank Barbara, for her pursuit of better care for women and for all veterans.

Pages

Recommended Reading

Air pollution contribution to lung cancer may be underestimated
Federal Practitioner
FDA approves Enhertu (trastuzumab deruxtecan) for HER2 lung cancer
Federal Practitioner
The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single Center
Federal Practitioner
A look at lung cancer screening in resource-limited countries
Federal Practitioner
Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis
Federal Practitioner
Does PREDICT accurately estimate breast cancer survival?
Federal Practitioner
Oncologists’ wealth and debt: COVID had little impact
Federal Practitioner
Estrogen replacement therapy in endometrial cancer survivors
Federal Practitioner
Where women’s voices still get heard less
Federal Practitioner
Pervasive ‘forever chemical’ linked to liver cancer
Federal Practitioner